| Industry | 批发和零售业 | ||||||||||||||||||||||||
| Company Introduction | 健民药业集团股份有限公司是一家以中药研发、生产和销售为主业,重点开发市场急需的小儿用药,老年用药和重大疑难病症用药,构建以中药现代化、产业化为基础,以高新技术药品为支撑的公司.公司是全国中成药小儿用药生产基地、全国重点中药企业之一.公司现拥有十余个子公司,集生产、科研、经贸于一体,综合实力跻身于行业50强.公司重点开发市场急需的小儿用药,老年用药和重大疑难病症用药,成功研制和开发出了龙牡壮骨颗粒、健民咽喉片、健脾生血颗粒等为代表的名牌系列产品,产品行销全国,并远销东南亚及欧美国家和地区。 | ||||||||||||||||||||||||
| Main Business | 中成药的研发、生产和销售，重点开发小儿用药、老年用药和重大疑难病症用药 | ||||||||||||||||||||||||
| Legal Representative | 何勤 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 周捷 | ||||||||||||||||||||||||
| Solicitors | 湖北天元兄弟律师事务所 | ||||||||||||||||||||||||
| Auditors | 武汉众环会计师事务所有限责任公司 | ||||||||||||||||||||||||
| Tel No | 027-84523350 | ||||||||||||||||||||||||
| Fax No | 027-84523350 | ||||||||||||||||||||||||
| Website | www.whjm.com | ||||||||||||||||||||||||
| Ir.jmjt@whjm.com；Jie.zhou@whjm.com；Hong.cao@whjm.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 19/04/2004 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 3.410 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 1.200 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 14.653 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 6.412B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |